共 141 条
- [21] Hasler E(2014)Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy EJNMMI Res. 4 58-71
- [22] Prettyjohns M(1990)Leuprolide therapy for prostate cancer: An association with scintigraphic ''flare'' on bone scan Clin Nucl Med. 15 485-94
- [23] Bombardieri E(2009)Cook G, deSouza NM: Imaging metastatic bone disease from carcinoma of the prostate Br J Cancer. 101 1225-79
- [24] Aktolun C(2003)Prostate carcinoma: defining therapeutic objectives and improving overall outcomes Cancer. 97 758-201
- [25] Baum RP(2012)Kim HJ, len-Auerbach M, Poon C Bridges J et al. Computer-aided quantitative bone scan assessment of prostate cancer treatment response. Nucl Med Commun. 33 384-91
- [26] Bishof-Delaloye A(2014)van der KT et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 65 467-116
- [27] Buscombe J(2003)Society of nuclear medicine procedure guideline for bone scintigraphy Bone Scintigraphy. 205 209-59
- [28] Chatal JF(2010)Bone scanning with sodium 18F-fluoride PET and PET/CT. German guideline Version 1.0. Nuklearmedizin 49 195-69
- [29] Zacho HD(2012)Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies BMJ. 345 883-undefined
- [30] Barsi T(2010)Appropriate statistical methods are required to assess diagnostic tests for replacement, add-on, and triage J Clin Epidemiol. 63 1109-undefined